Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP4 receptor partial agonist for the treatment of pain
Healy, Mark P., Allan, Amanda C., Bailey, Kristin, Billinton, Andy, Chessell, Iain P., Clayton, Nicholas M., Giblin, Gerard M.P., Kay, Melanie A., Khaznadar, Tarik, Michel, Anton D., Naylor, Alan, Price, Helen, Spalding, David J., Stevens, David A., Swarbrick, Martin E., Wilson, Alexander W.
Published in Bioorganic & medicinal chemistry letters (01.06.2018)
Published in Bioorganic & medicinal chemistry letters (01.06.2018)
Get full text
Journal Article
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
Rini, Brian I, Powles, Thomas, Atkins, Michael B, Escudier, Bernard, McDermott, David F, Suarez, Cristina, Bracarda, Sergio, Stadler, Walter M, Donskov, Frede, Lee, Jae Lyun, Hawkins, Robert, Ravaud, Alain, Alekseev, Boris, Staehler, Michael, Uemura, Motohide, De Giorgi, Ugo, Mellado, Begoña, Porta, Camillo, Melichar, Bohuslav, Gurney, Howard, Bedke, Jens, Choueiri, Toni K, Parnis, Francis, Khaznadar, Tarik, Thobhani, Alpa, Li, Shi, Piault-Louis, Elisabeth, Frantz, Gretchen, Huseni, Mahrukh, Schiff, Christina, Green, Marjorie C, Motzer, Robert J
Published in The Lancet (British edition) (15.06.2019)
Published in The Lancet (British edition) (15.06.2019)
Get full text
Journal Article
Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety Results
Kato, Terufumi, Seto, Takashi, Nishio, Makoto, Goto, Koichi, Yamamoto, Noboru, Okamoto, Isamu, Tao, Liang, Yu, Wei, Khaznadar, Tarik, Tajima, Kosei, Shibata, Masahiko, Seki, Akihiro, Yamamoto, Nobuyuki
Published in Drug safety (01.02.2018)
Published in Drug safety (01.02.2018)
Get full text
Journal Article
Patient-reported outcomes (PROs) in IMmotion151: Atezolizumab (atezo) + bevacizumab (bev) vs sunitinib (sun) in treatment (tx) naive metastatic renal cell carcinoma (mRCC)
Escudier, Bernard, Motzer, Robert J., Rini, Brian I., Powles, Thomas, McDermott, David F., Suarez, Cristina, Bracarda, Sergio, Stadler, Walter Michael, Donskov, Frede, Gurney, Howard, Oudard, Stephane, Uemura, Motohide, Lam, Elaine Tat, Grüllich, Carsten, Ding, Beiying, Khaznadar, Tarik, Quach, Caroleen, Piault, Elisabeth, Schiff, Christina, Atkins, Michael B.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP 4 receptor partial agonist for the treatment of pain
Healy, Mark P, Allan, Amanda C, Bailey, Kristin, Billinton, Andy, Chessell, Iain P, Clayton, Nicholas M, Giblin, Gerard M P, Kay, Melanie A, Khaznadar, Tarik, Michel, Anton D, Naylor, Alan, Price, Helen, Spalding, David J, Stevens, David A, Swarbrick, Martin E, Wilson, Alexander W
Published in Bioorganic & medicinal chemistry letters (01.06.2018)
Get full text
Published in Bioorganic & medicinal chemistry letters (01.06.2018)
Journal Article